GAMMA Investing’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.5K Buy
735
+266
+57% +$21.4K ﹤0.01% 2142
2026
Q1
$35.4K Buy
469
+140
+43% +$10.3K ﹤0.01% 2414
2025
Q4
$22.3K Buy
329
+69
+27% +$4.31K ﹤0.01% 2544
2025
Q3
$14.8K Buy
260
+5
+2% +$296 ﹤0.01% 2674
2025
Q2
$14.1K Sell
255
-14
-5% -$657 ﹤0.01% 2640
2025
Q1
$11.8K Sell
269
-70
-21% -$3.05K ﹤0.01% 2676
2024
Q4
$14.6K Buy
339
+185
+120% +$8.33K ﹤0.01% 2429
2024
Q3
$6.88K Buy
+154
New +$6.37K ﹤0.01% 2614

Other funds holding DBD

GAMMA Investing's DBD Position: Q2 2026 in Review

GAMMA Investing increased its Diebold Nixdorf (DBD) stake by 57% in Q2 2026, buying an estimated $21.4K and bringing the position to 735 shares worth $62.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2142.

GAMMA Investing first reported a position in DBD in Q3 2024 and has held it in 8 quarters since. 18 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • GAMMA Investing held 735 shares of Diebold Nixdorf worth $62.5K as of Q2 2026.
  • GAMMA Investing bought 266 Diebold Nixdorf shares in Q2 2026, an estimated $21.4K.
  • Diebold Nixdorf made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2142 holding.
  • GAMMA Investing first reported a position in Diebold Nixdorf in Q3 2024 and has held it in 8 quarters since.
  • 18 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.